San Diego, CA, United States of America

Chrisopher McBride

This inventor holds 1 USPTO granted patent. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chrisopher McBride. Retrieved from https://idiyas.com/inventor/chrisopher-mcbride

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christopher McBride: Innovator in Polo-like Kinase Inhibitors

Introduction

Christopher McBride is a notable inventor based in San Diego, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of polo-like kinase inhibitors. His work has the potential to impact various therapeutic areas.

Latest Patents

Christopher McBride holds a patent for polo-like kinase inhibitors. The patent details compounds of a specific formula designed for use with kinases. It also includes pharmaceutical compositions, kits, and articles of manufacture that comprise such compounds. Additionally, the patent outlines methods and intermediates useful for making these compounds, as well as methods of using them.

Career Highlights

Christopher is currently employed at Takeda Pharmaceutical Company Limited, where he continues to advance his research and development efforts. His work at Takeda has allowed him to focus on innovative solutions in the pharmaceutical industry.

Collaborations

He collaborates with talented coworkers, including Sheldon Cao and Victoria Feher. Their combined expertise contributes to the success of their projects and the advancement of their research.

Conclusion

Christopher McBride is a dedicated inventor whose work in polo-like kinase inhibitors showcases his commitment to innovation in the pharmaceutical field. His contributions are paving the way for new therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…